Milind Javle
@javlemilind
Hubert L and Olive Stringer Professor GI Medical Oncology and Attending Physician, MD Anderson Cancer Center
Chair, NCI Task Force Hepatobiliary Cancers
ID: 1357532036475596800
05-02-2021 03:30:48
773 Tweet
1,1K Followers
370 Following
Wonderful to be Great Debates with Dr. Cathy Eng and Yelena Y. Janjigian MD debating the eloquent Dr Diedre Cohen!
Interesting abstract released for Asco 2024. Liver transplant for CRC: first positive prospective trial. Ready for prime time? Exciting work ILTS Dr. Cathy Eng Sudha Kodali Gonzalo Sapisochin meetings.asco.org/abstracts-pres…
🔥off the press: Durvalumab plus GemCis in advanced biliary tract cancer: TOPAZ-1 phs-3 The Lancet Gastroenterology & Hepatology 🧐Updated OS data, including long-term survivors & OS by ORR 👇my personal Share Link: authors.elsevier.com/c/1jAbO8nByrCh… ESMO - Eur. Oncology EASLnews ILCA Cholangiocarcinoma Foundation #livertwitter
CCF is pleased to share a newly published paper in the The Lancet Gastroenterology & Hepatology with updated survival data from the TOPAZ-1 trial, which established durvalumab as the standard of care immunotherapy when added to cisplatin and gemcitabine chemotherapy. thelancet.com/journals/langa…
New article alert!🚨 Comparison of age stratified data from one of the highest volume centres in India managing Gallbladder cancers. Link👇🏽 hpbonline.org/article/S1365-… Mahesh Goel Shraddha Patkar Itaru Endo IHPBA @HPBjournal Aditya Kunte Gurudutt P. Varty Swapnil Patel
sciencedirect.com/science/articl… Important data in her2/neu mutations (not amplifications) in many cancers with trastuzumab/ deruxtecan Cholangiocarcinoma Foundation ENSCCA_2020 AMMF
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study Cholangiocarcinoma Foundation ENSCCA_2020 browzine.com/articles/61587…
instagram.com/reel/C8zLe9kSF… Jarurat.care Cholangiocarcinoma Foundation Melinda Bachini Lisa Craine Amol Patel From The amazing Priyanka Joshi on what is a caregiver?
Released today: 📣 New Sound Bites video on the TOPAZ-1 trial in the treatment of BTC presented by Dr. Milind Javle ➡️ hubs.la/Q02DS-W80 #TOPAZ1 #oncologynews
Impressive resource & dataset for those researching #Cholangiocarcinoma & other #BileDuct cancers. Preprint from Francisca Vazquez Gaddy Getz & Nabeel Bardeesy Mass General Cancer Center Broad Institute. Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and
Congratulations Daniel Stix with Spanish PM Pedro Sánchez Very proud for you and your parents our lovely friends Silvia and David Stix. Good luck for the The Olympic Games NBC Olympics & Paralympics
Results from DESTINY-CRC02 published in The Lancet Oncology. Among patients with pretreated, HER2+ mCRC, the lower dose of T-DXd (5.4 mg/kg) led to higher ORR and longer PFS than the higher dose (6.4 mg/kg), with nearly half the rate of ILD. Less can be more. thelancet.com/journals/lanon…
Congrats Ethan Ludmir MD and Chad Tang, MD! This MD Anderson Cancer Center P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in #PancreasCancer pts with oligometastatic dz treated with metastasis-directed therapy+sys tx vs. sys tx alone. #radonc #endcancer ascopubs.org/doi/10.1200/JC…
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: ascopubs.org/doi/abs/10.120… @thejusjay Alok Khorana, MD #gicsm
Good to catch up with fantastic colleagues in Brazil. Thanks for a wonderful meeting Paulo Hoff oncologiabrasilia A.C.Camargo Cancer Center H.I.Albert Einstein
Restrictive Strategy vs Usual Care for Cholecystectomy in Patients With Abdominal Pain and Gallstones: 5-Year Follow-Up of the SECURE Randomized Clinical Trial JAMA Surgery jamanetwork.com/journals/jamas…